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Background: S. erythraea is a Gram-positive filamentous bacterium used for the industrial-scale production of
erythromycin A which is of high clinical importance. In this work, we sequenced the whole genome of a high-
producing strain (E3) obtained by random mutagenesis and screening from the wild-type strain NRRL23338, and
examined time-series expression profiles of both E3 and NRRL23338. Based on the genomic data and transcriptpmic
data of these two strains, we carried out comparative analysis of high-producing strain and wild-type strain at both
the genomic level and the transcriptomic level.
Results: We observed a large number of genetic variants including 60 insertions, 46 deletions and 584 single
nucleotide variations (SNV) in E3 in comparison with NRRL23338, and the analysis of time series transcriptomic data
indicated that the genes involved in erythromycin biosynthesis and feeder pathways were significantly up-regulated
during the 60 hours time-course. According to our data, BldD, a previously identified ery cluster regulator, did not
show any positive correlations with the expression of ery cluster, suggesting the existence of alternative regulation
mechanisms of erythromycin synthesis in S. erythraea. Several potential regulators were then proposed by
integration analysis of genomic and transcriptomic data.
Conclusion: This is a demonstration of the functional comparative genomics between an industrial S. erythraea strain
and the wild-type strain. These findings help to understand the global regulation mechanisms of erythromycin
biosynthesis in S. erythraea, providing useful clues for genetic and metabolic engineering in the future.
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reproduction in any medium, provided the orThe antimicrobial spectrum of erythromycin A is simi-
lar to that of penicillin, and Erythromycin A is often
prescribed as an alternative for patients with an allergy
to penicillin. Moreover, a series of derivatives of ery-
thromycin, derived by chemical and biotechnological
transformation, have been shown to have antiparasitic,
antineoplastic, immunosuppressant, neurotrophic, anti-
inflammatory, and gastroenteric therapeutic activities
[2]. In view of the high clinical importance of erythro-
mycin and its derivatives, extensive efforts have been
devoted to increase the erythromycin production in
S. erythraea which has even been studied as a model
system for antibiotic production [3,4].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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provement has been carried out mainly by multiple
rounds of random mutagenesis and selection [2,5,6].
Meanwhile, erythromycin productivity has also been en-
hanced by the optimization of fermentation process
[7,8]. Since 1990s, genetic studies have provided insights
into the genes involved in erythromycin biosynthesis,
and the erythromycin gene cluster was found to contain
20 genes arranged in four major polycistronic units
[9-11], which facilitated strain improvements by genetic
and metabolic engineering [12-15]. Recently, BldD, a key
developmental regulator in actinomycetes [16,17], was
identified to positively regulate the synthesis of erythro-
mycin at the transcriptional level [18], which opened the
possibility of enhancing the erythromycin production by
modifying the regulation mechanism. However, bldD
was later reported to exhibit an opposite gene expression
pattern with respect to most of ery genes in a higher-
producing strain [6], which made the regulation mech-
anism underlying erythromycin production complicated
and confusing. As a result, the engineering works have
still been focusing on erythromycin biosynthesis pathway
[19] and feeder pathway [15,20].
Noticing that genetic modifications targeting to crucial
genes are sometimes lethal, people realized that omics
data may pave the way for the productivity optimization
at the whole-genome scale from the perspective of sys-
tems biology [21]. In recent years, the development of
high-throughput technologies has revived efforts to in-
crease strain productivity [22-26]. For example, a new
regulator of avermectin biosynthesis in Streptomyces
avermitilis, HrdB, was identified through transcriptome
profiling in our previous study, and increased productiv-
ity was achieved by modifying the hrdB gene [27].
The complete genome of S. erythraea strain NRRL23338
was sequenced in 2007 [1], which allows more rational im-
provement of strains to achieve high-titer erythromycin
production. Several expression microarray experiments
based on the wild-type strain and mutant strains including
both overproducing and defected strains were later on re-
leased [6,28-30]. It was found that genes involved in
erythromycin biosynthesis cluster and feeder pathway
were up-regulated at the transcriptional level in overpro-
ducing strains. Even though, the global genetic basis for
erythromycin biosynthesisis far from full elucidation.
In this work, we sequenced the whole genome of a high-
producing strain (E3) obtained from random mutagenesis
and screening, and examined time-series expression profiles
of both E3 and the wild-type strain NRRL23338. A large
number of genomic variations, including 60 insertions, 46
deletions and 584 single nucleotide variations (SNV) were
identified in E3 in comparison with NRRL23338; the genes
involved in erythromycin biosynthesis and feeder pathways
were significantly up-regulated during the 60 hours time-course. According to our data, bldD did not show any
positive correlations with the expression of ery cluster, im-
plying alternative regulation mechanisms of erythromycin
synthesis in S. erythraea, and/or the combinatorial effects
of various regulation mechanisms. By integrating com-
parative genomic data to comparative transcriptomic data,
we proposed several regulators which are potentially
associated with erythromycin production. This functional
comparative genomics work represents an important step
towards understanding the over-producing mechanism of
S. erythraea strain E3 on a genomic scale, and provided
useful clues to strain engineering for improved production
of erythromycin.
Results
S. erythraea E3 strain genome features and comparisons
with NRRL23338 strain
The main features of the genome sequence of high-
producing strain E3 are schematically represented in
Figure 1, and summarized in comparison with wild-type
strain NRRL23338 in Table 1.
The genome of strain E3 is comprised of a single cir-
cular chromosome of 8,199,523 bp, which is 0.16%
smaller than that of NRRL23338 (8,212,805 bp) [1]. The
average GC content of the E3 genome is 71.0%, almost
the same as NRRL23338 (71.1%) [1]. The replication
origin of E3 genome was determined by homology map-
ping to NRRL23338, which was identified based on GC
skew and the position of the replication origin oriC. In
strain E3, there is a definite GC skew inversion at oriC
and also on the opposite side of the chromosome to
oriC. The initiation codon of the dnaA gene, adjacent to
oriC, was set as the starting point for numbering the
coding sequences.
The overall features of E3 genome are highly similar to
NRRL23338 (Table 1). In summary, E3 contains a total
of 7,257 predicted coding sequences, including 7195
protein-coding sequences (CDSs), 50 tRNA genes, and
12 rRNA genes in four copies of 16S-23S-5S rRNA op-
erons. The coding density is 84.9%, identical to strain
NRRL 23338. The 50 tRNA genes encode all tRNAs re-
quired for protein biosynthesis. The rRNA gene number
of E3 strain, 12, is different from that of NRRL23338
reported earlier, 16 [1]. To address this doubt, we care-
fully compared the rRNA coding regions of two strains,
and found that their sequences are completely identical.
We then noticed that there are actually only 12 rRNA
coding gene records of NRRL23338, but not the claimed
16, deposited in NCBI. All these observations suggest
that there should be a total of 12 rRNA genes in both
E3 and NRRL23338. Among the 7195 CDSs, a putative
function could be ascribed to 4783 (66.5%) of these.
Of the rest, 829 (11.5%) showed similarity to hypo-
thetical proteins in other genomes, and 1,583 (22.0%)
Figure 1 Schematic representation of the S. erythraea E3 genome. The outer scale is numbered in megabases from the origin of replication
(ori) and the first circle indicates the core (red) and noncore (blue) regions, and the boundaries between them are mark by gradient colors.
Circles 2, 3 and 4 (from the outside in), whole genome alignment (by Mummer) between S. erythraea and M. tuberculosis, N. farcinica, S. coelicolor,
respectively (conservation of sequence regions are marked by gradient colors: blue, yellow, red. Most conserved regions are in red.). Circles 5 and
6, all genes (forward and reverse strand, respectively) colored corresponding to the COG functional assignment. Circle 7, tRNAs (red) and rRNAs
(skyblue). Circle 8, GC content; circle 9, GC skew ((G – C/G + C), plum indicates values >1, lightblue values <1).
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public databases.
Similar to the NRRL23338 strain, the core region of
the genome, extending either side of the oriC and
ending in the regions of markedly lower GC content
(Figure 1), accounts for a total of 4.3 Mbp. In compari-
son with the regions outside the core, the core regionTable 1 General features of the S. erythraea E3 and
NRRL23338 genome
Component of the genome NRRL23338 E3
Length 8,212,805 bp 8,199,523 bp
G + C content 71.10% 71.00%




CDS, protein-coding sequence. *attributed to a statistical error of the
previous literature.shows substantial conservation when comparing with
other actinobacteria (e.g. M. tuberculosis, N. farcinica,
S. coelicolor, Figure 1) [1].
The genomic changes in E3 relative to NRRL23338 in-
volve 60 insertions, 46 deletions and 584 single nucleo-
tide variations (SNVs) (see Additional file 1: Table S1).
Most of the variations occur in intragenic regions: 40
out of 60 insertions, 28 out of 46 deletions and 511 out
of the 584 SNVs are located in intragenic regions, and
the other 20 insertions, 18 deletions and 73 SNVs are lo-
cated in intergenic regions (Additional file 1: Table S1).
Based on the intragenic variations, which are expected
to contribute to the altered phenotype, we identified 139
proteins whose amino acid sequence is changed by
SNVs, 28 proteins and 32 proteins which are affected by
deletions and insertions respectively (Additional file 2:
Table S2, Additional file 3: Table S3, Additional file 4:
Table S4). These altered proteins are overrepresented in
the COG categories of “replication, recombination and
repair” with p-value of 4.20E-08, and “signal transduc-
tion mechanisms” with p-value of 0.005.
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nomes is an 11 Kb deletion which spans 11 genes includ-
ing a predicted integrase and a predicted aminoglycoside
phosphotranserase as well as 9 hypothetical proteins
(Additional file 3: Table S3). It is likely to be a prophage
(integrated plasmid) because its gene content and
organization are very similar to the isolated plasmids
pSE101 and pSE211 previously identified in strain
NRRL23338 [1]. Moreover, E3 genome are found to con-
tain integrated pSE101 and pSE211, one copy for each
plasmid, which include14 and 27 candidate protein-
encoding genes respectively, spanning 10.9 kb and 17.3 kb
[1]. It is noticeable that the integrated plasmid regions in
strain E3 and the isolated pSE101 and pSE211 in strain
NRRL23338 share an integrase (recombinase) gene.
Comparative transcriptome analysis between E3 and
NRRL23338 strains
Beyond the whole genome sequencing of two S. erythraea
strains, high-producing E3 and the wild-type NRRL23338,
we designed a time-course microarray experiment to
investigate the gene expression profiles of E3 and
NRRL23338. Six time points 10 h, 16 h, 24 h, 36 h, 48 h,
60 h were chosen according to the growth curve [28]Figure 2 Heatmap of the 1500 differentially expressed genes betwee
the dendrogram on the left is the clustering result, the sample names (M: m
represents the time point) are list on the bottom.and erythromycin production curve (Additional file 5:
Figure S1) of S. erythraea.
A total of 1500 genes (approximately 20% of all
S. erythraea genes) were identified to be differentially
expressed (DE) in terms of between-time series, which
emphasizes on the expression variation at the same time
point between two strains. The differentially expressed
genes (DEGs) were then clustered into 3 groups according
to the pattern of expression change: up-regulated in strain
E3, down-regulated in strain E3, different expression
pattern across time between two strains (Figure 2 and
Additional file 6: Table S5).
According to the functional enrichment analysis results
based on COG category annotation [31] (Additional file 7:
Table S6), [C] energy production and conversion and [Q]
Secondary metabolites biosynthesis, transport and catab-
olism are up-regulated in strain E3; [O] posttranslational
modification, protein turnover, chaperones and [E] amino
acid transport and metabolism are over-represented both
in up-regulated genes and down-regulated genes in strain
E3, indicating that these functions present different
activities in two strains, and some of the related genes
are up-regulated in E3 while some are down-regulated
(Additional file 7: Table S6). Additionally, [L] replication,n NRRL23338 and E3. Red = up-regulated, Green = down-regulated,
odel strain NRRL23338, E: high-producing strain E3, the number
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different expression profile across time between two
strains. Among them, we carefully scrutinized the specific
pathways related to fermentation physiology, including
erythromycin biosynthesis, feeder pathway, transporters,
energy production and secondary metabolite synthesis.
Erythromycin biosynthesis and feeder pathways
Noticeably, all genes (SACE_0712-0721, SACE_0723-
0734) in erythromycin biosynthesis cluster (ery cluster)
were dramatically up-regulated (Mean: 5.8-fold, Max:
30.8-fold) for the duration of 60 hours time-course in the
overproducing strain E3 in comparison with the wild-type
NRRL23338 (Additional file 8: Table S7), consistent
with previous observations that the expression of ery clus-
ter was correlated to erythromycin production [11,32].
Moreover, the feeder pathway was also activated in E3
(Additional file 6: Table S5, Additional file 8: Table S7). In
many streptomycetes, at least four pathways have been
characterized to be connected to the methylmalonyl-CoA
pool (precursor of erythromycin biosynthesis): MCM
pathway which catalyzes the reversible isomerization
of succinyl-CoA and methymalonyl-CoA, CCR pathway
utilizing crotonyl-CoA reductase or adenosylcobalamin-
dependent isobutyryl-CoA mutase, MeaA pathway from
acetoacetyl-CoA, and PCC pathway through carboxylation
of propionyl-CoA by proprionyl-CoA carboxylase. It was
found that S. erythraea has no CCR pathway and MeaA
pathway for the precursor supply [1]. Genome sequence
analysis suggests that PCC pathway may play a role in
precursor flow in S. erythraea. In S. erythraea at least
five genetic loci (SACE_0026-0028; SACE_3241-3242;
SACE_3398-3400; SACE_3856/6509; SACE_4237) might
encode biotin-dependent carboxylases catalyzing carboxyl-
ation of propionyl-CoA to methylmalonyl-CoA. So far, it
is still unclear which gene set makes a contribution to
erythromycin biosynthesis. Comparative transcriptome
analysis found that only SACE_4237 gene displayed ob-
vious up-regulation in high-producing strain E3, indi-
cating that over-expression of SACE_4237 may enhance
supply of methylmalonyl-CoA through carboxylation of
propionyl-CoA. Further experiments are required to
validate this assumption.
The expression of genes encoding key enzymes of
carbon and fatty acid metabolisms was also signifi-
cantly changed in turn affecting the flux of metabolites
through erythromycin feeder pathways. The industrial
strain E3 exhibited an impressive activation of fatty
acid catabolic pathway, glycolysis/citrate cycle path-
ways, valine, leucine and isoleucine degradation pathway
that supplies propionyl-CoA and methymalonyl-CoA
for biosynthesis of 6-deoxyerythronolide B. The genes
coding for key enzymes of valine, leucine and isoleu-
cine catabolic pathway (fadE1, SACE_4125 coding foracyl-CoA dehydrogenase; echA7, SACE_4571 coding
for enoyl-CoA hydratase/isomerase-like activity; pksG,
SACE_4570 encoding hydroxymethylglutaryl-CoA syn-
thase; mmsA1, SACE_4672 encoding methylmalonate-
semialdehyde dehydrogenase) were strongly over-expressed
in industrial strain E3. Up-regulation of genes involved
in fatty acid catabolic pathway, including SACE_4038
(fadD) coding for long-chain acyl-CoA synthetase,
SACE_4125, SACE_4571, SACE_6363 (fadA) encoding
acetyl-CoA acetyltransferase, maybe also lead to the
increased propionyl-CoA in strain E3. The glycolysis/
citrate cycle pathways are connected to the feeder
pathway of erythromycin biosynthesis via succinyl-
CoA, an important metabolite of the Krebs cycle.
Transcription of gap, pgk, tpiA and eno in glycolysis
was moderately elevated in strain E3. Most genes of
TCA cycle, including SACE_1638 (sucB), SACE_3674
(mdh), SACE_3811 (acn), SACE_3926/SACE_3927 (korA),
SACE_3952 (pdhA2), SACE_3953 (pdhB1), SACE_3954
(bkdC2), SACE_4581 (citE3), SACE_6118 (pyc), SACE_
6636 (isocitrate dehydrogenase) and SACE_6668/6669
(sucC), showed higher expression level, as compared to
wild-type strain. It was found that the variations affected
three genes of the Krebs cycle, including SACE_0633 (cit-
rate synthase), SACE_6636 and SACE_6668 (Additional
file 2: Table S2, Additional file 3: Table S3, and Additional
file 4: Table S4).
These results demonstrate that enhanced level of
erythromycin biosynthesis in strain E3 is likely to be at-
tributed to the alterations in many pathways, and the
up-regulation of erythromycin biosynthesis and feeder
pathway seemed to be crucial events.
Transporters
Differential expression analysis showed that genes en-
coding phosphate transport system (SACE_7097-7099,
SACE_6643-6645), Iron ion uptake system (SACE_4076-
4077), D-methionine transport system (SACE_0804-
0806), and sulfonate/nitrate/taurine transport system
(SACE_0556, SACE_1672-1674) were significantly acti-
vated, among which the transport of D-methionine
(SACE_0806) was most activated (5.9 folds). PhoP-
regulated phn operon (SACE_6643-6645) was induced
by 5.5 folds. Moreover, several genes involved in nitro-
gen sources intake and assimilation were inhibited in E3
strain, including the oligopeptide transporter operons
(SACE_0257-0260, SACE_0844-0848), amino acid trans-
porter operon (SACE_6266-6269), glutamate transporter
operon (SACE_1743-1746), glutamine transporter op-
eron (SACE_7284-7286), and ammonium transporter
gene (amt, SACE_6062). The most repressed gene was amt
(12.5 folds). It was observed that the genes related to phos-
phate and nitrogen transport were differentially expressed
between two strains. Compared with NRRL23338, E3
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nitrogen-metabolism through the entire time-course.
These observations indicated that P-N metabolism bal-
ance may play an important role in the overproducing
strain E3.
Energy production
Generally speaking, the expression of genes involved in
bioenergetics and oxidative phosphorylation was mod-
erately enhanced in industrial E3 strain, which may con-
tribute to energy supply for erythromycin production.
The most important members of this group are nuo
operon encoding NADH dehydrogenase I (nuoN-A,
SACE_6889-6902) and atp operon coding for ATP
synthases (atpDGAHFEB, SACE_6280-6286). This is
consistent with the observation that the nuo genes
exhibited higher expression level in mutant rif1 (higher
producer) than wild type and mutant rif6 strains (lower
producer) [6].
Secondary metabolite synthesis
There are 25 clusters (involving a total of 202 genes) for
the biosynthesis of polyketides, terpenes and non-
ribosomally synthesized peptides in the S. erythraea
genome. Three clusters (tpc2, tpc3, and tpc4) of the six
terpene synthase gene clusters, three PKS gene clustersFigure 3 Heatmap of secondary metabolite synthesis gene clusters b
regulated, the dendrogram on the left is the clustering result, the sample n
number represents the time point) are list on the bottom. Genes in the sam
cluster ery, tpc2, tpc3, pks3, pks6, nrps5 and hopp and rpp clusters are marke(pks3, pke, and pks6), and one gene cluster encoding
nonribosomal peptide synthetase (nrps1) were acti-
vated in strain E3 in comparison with NRRL23338
(Figure 3). Among these up-regulated gene clusters,
pks6 (SACE_4567-4577) showed the most significantly
induced expression (Mean: about 5.7 folds; Max: about
21 folds). In contrast, only two gene clusters for production
of secondary metabolites (nrps6 and rpp) were inhibited in
E3. This indicated the general enhancement of secondary
metabolite synthesis in high producing strain.
Since differential coexpression analysis (DCEA) is much
more useful than traditional differential expression ana-
lysis (DEA) for investigating the global transcriptional
mechanisms underlying the associated phenotypic changes
[33,34], we then ranked genes according to its differential
coexpression with the others in the coexpression network
by using DCp method [35] (Additional file 8: Table S7).
Noticeably, Ure operon, nar operon, nir operon, glnA2,
glnB), involved in nitrogen metabolism, were differentially
coexpressed, implying an altered coordination of nitrogen
metabolism with the other functions in strain E3 com-
pared with NRRL23338.
Functional genomics analysis
After separately analyzing the genomic data and trans-
criptomic data, we set out to explore the links betweenetween NRRL23338 and E3. Red = up-regulated, Green = down-
ames (M: model strain NRRL23338, E: high-producing strain E3, the
e gene cluster are marked in the same color, the well clustered gene
d on the left.
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provide an opportunity to identify causative mutations
accounting for the high productivity, and eventually
elucidate the regulation mechanisms underlying the
erythromycin synthesis.
We first focused on the ery cluster genes, including
the promoter regions, and found that they were identi-
cal at the genomic level in both strains, but significantly
up-regulated at the transcriptional level in high-
producing strain E3. We then resorted to the upstream
regulatory factors of ery cluster. The coordinate alter-
ation of the ery cluster gene expression suggested that
the ery cluster may be co-regulated by the regulator(s),
whose differences at the sequence level in two strains
may lead to the expression difference of ery cluster. The
transcriptional regulator, bldD (SACE_2077), which was
reported to positively regulate the ery cluster [18], how-
ever, showed lower expression level in overproducing
strain E3, opposite to the ery genes. This was consistent
with the data reported more recently [6]. It seems that
the regulatory effect of of bldD on ery cluster needs fur-
ther investigation. At least, there must be other regula-
tory factors involved in the transcriptional regulation of
ery genes.
We manually checked the annotation information of
these genomic variant genes, and found a total of 18 poten-
tial regulators (Additional file 9: Table S8 and Additional
file 10: Dataset S1). According to the comparison to the se-
quence of orthologous genes in closely related species, 7
genes were supposed to be mutated in E3 and 2 genes were
supposed to be mutated in NRRL23338; 11 genes were un-
certain as no orthologues of them were found. We focused
on the two regulators, MtrA and MoxR, which were mu-
tated in the functional domain regions in strain E3.
In S. erythraea, SACE_6447-SACE_6445 operon en-
codes proteins that are homologous to the products of
the mtrAB-lpqB genes of Mycobacterium tuberculosis.
MtrA is a member of the OmpR/PhoB family of re-
sponse regulators, forming a two-component system
(TCS) with its cognate sensor kinase (MtrB). According
to NCBI conserved domain database (CDD, http://www.
ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml), Pfam (http://
pfam.janelia.org), and the three-dimensional structure
drawn from Mycobacterium tuberculosis [36], MtrA pos-
sesses two domains, an N-terminal regulatory domain
displaying the classic α/β fold and a C-terminal DNA-
binding domain with a winged helix-turn-helix. MtrA
has been related to the regulation of diverse cellular
functions [37-40]. In S. coelicolor, SCO3011-SCO3013
operon appears to be an orthologue of the mtrAB-lpqB
operon. The function of this operon is unclear but null
mutations in mtrB and lpqB affect normal septation and
sporulation. Attempts to disrupt mtrA have so far been
unsuccessful, suggesting this may also be an essentialgene in Streptomyces [41]. Analysis of the limited experi-
mental research available on MtrAB suggests that the pri-
mary role of MtrAB is in regulating cell cycle progression,
the composition and function of the cell envelope or, per-
haps more likely, in responding to general stresses that
could ultimately inhibit cell division. However, many ques-
tions remain about the MtrAB two-component system in
Streptomyces, such as: how does MtrAB govern growth
and MtrAB govern growth and development? How does
MtrAB play a role in antibiotic biosyntheses? To date, no
experimental work has been performed on this operon, so
information about its function in the cell is not available.
Recently the direct repeats of GTCACAgcg-like consensus
sequences (MtrA-Box) recognized by MtrA were identi-
fied in M. tuberculosis [42], but we failed to find it in
S. erythraea genome, indicating that S. erythraea has dis-
tinct MtrA binding site upstream of the target genes [43].
Although both mtrA and mtrB werenot differentially
expressed between two S. erythraea strains, MtrAofE3
strain had two amino acids deleted (H196 and V197),
compared toM. tuberculosis and S. erythraea NRRL23338.
The deletion was located in the C-terminal domain,
and specifically, next to the DNA-binding site, V195
(Additional file 9: Table S8 and Additional file 10:
Dataset S1).
We therefore applied homology modeling to study the
variation sites of E3 MtrA in the structural context. It
was found that the deleted sites in the M. tuberculosis
model was in an α-helix (Additional file 11: Figure S2),
which may lead to the distortion of the related helix or
even more. This probably interfere its DNA binding ac-
tivity, and thus the regulatory activity of MtrA. Follow-
up functional experiments of MtrA in S. erythraea will
help to identify its regulatory role in antibiotic synthesis.
We also observed another interesting regulator, MoxR
(SACE_3795). The MoxR family is a subset of AAA +
ATPases, a large, diverse group of ATPases associated
with various cellular activities including cell-cycle regu-
lation, DNA repair and replication, protein proteolysis
and disaggregation, and so on. MoxR is often observed
in close proximity to Von Willebrand Factor Type A
(VWA) proteins and are likely to function with them to
form a chaperone system. More importantly, MoxR also
acts as DNA helicases and transcription factors [44]. In
S. erythraea, the moxR gene is immediately adjacent to
two genes (SACE_3794 and SACE_3793) encoding VWA
proteins. A single-nucleotide variation (N133D) was iden-
tified in E3 moxR gene (Additional file 11: Table S2 and
Additional file 12: Figure S3), compared with NRRL23338
and other related species, such as Actinosynnema mirum
DSM 43827. When searching NCBI CDD, we found this
protein was a putative member of the AAA+ (ATPases
Associated with a wide variety of cellular Activities) super-
family. The sequence alignment showed that the variation
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(two residues away) and Walker B motif (related to Mg++
binding, one residue away), suggesting that the substitution
may perturb its activity of ATP and Mg++ binding, al-
though the homology modeling result did not provide fur-
ther evidence. Additionally, of the 18 regulator genes,
moxR gene was mostly strongly over-expressed in indus-
trial strain E3 compared with NRRL23338 (about 3-fold).
Discussion
Erythromycin and its semi-synthetic derivatives are
widely used in the clinic, and thus improved producers
are highly sought after. In recent years, the availability of
the entire genome sequence of S. erythraea has opened
the possibility of defining the erythromycin biosynthesis
mechanisms by using global approaches [1,28]. These
high-throughput approaches have led to the discovery
that BldD, a key developmental regulator in actinomy-
cetes [16,17], which activates the synthesis of erythro-
mycin at the transcriptional level [18]. Meanwhile, there
is evidence that increasing the flux through feeder meta-
bolic pathways strongly influences the erythromycin
yields, which has been recently obtained by engineering
the methylmalonyl-CoA metabolite node in S. erythraea
and in A. erythreum, a non-filamentous erythromycin A
producer [15,45,46].
In our present work, the comparative analysis of
S. erythraea overproducing E3 and wild-type NRRL23338,
at both genomic and transcriptomic level, indicate that ery
clustering for erythromycin synthesis is up-regulated in
E3 as expected, whereas E3 and NRRL23338 have iden-
tical ery genomic sequences (Figure 3). Furthermore,
the feeder pathways were also activated in E3 strain. This
could elevate the concentrations of propionyl-CoA and
methymalonyl-CoA, the precursor metabolites of erythro-
mycin production (starter unit and extender unit respect-
ively), and thus improve the erythromycin yield. Indeed,
increased supply of methylmalonyl-CoA has been demon-
strated to increase erythromycin production, which was
achieved by altering the metabolic flux distribution of its
different precursors through genetic manipulation [15].
The extender unit, methymalonyl-CoA, can be derived
from different pathways such as carboxylation of propionyl-
CoA and rearrangement of succinyl-CoA. The mutA and
mutB genes (SACE_5638, 5639) encode methylmalonyl-
CoA mutase (MCM), which catalyzes the reversible
isomerization of succinyl-CoA and methymalonyl-CoA.
Reeves et al. have proposed a metabolic model where in
carbohydrate-based fermentations MCM acts as a drain
on the methylmalonyl-CoA metabolite pool, and in oil-
based fermentations, MCM acts in the reverse direction
to fill the methylmalonyl-CoA pool [45]. The induction
or repression of mutAB may elevate or reduce concentra-
tions of methymalonyl-CoA to affect the erythromycinsynthesis rate depending on the medium. Therefore, over-
production of erythromycin was achieved by inactivating
the mutB in a carbohydrate-based medium [15], or by du-
plication of the MCM operon (mutA, mutB, meaB and
mutR) in an oil-based fermentation medium [20]. In this
study, the carbon flow under industrial medium condition
may be from succinyl-CoA to methylmalonyl-CoA.
Improvement of erythromycin production in E3 strain
could be at least partly attributed to the increase of
methylmalonyl-CoA pool as a result of the overexpression
of mutAB genes.
More interestingly, bldD has the same sequences in two
strains, and is down-regulated in the overproducing E3,
which is contrary to the observation reported by the BldD
finder [18], while consistent with a more recent literature
[6]. Other possible regulation mechanisms of erythro-
mycin synthesis in S. erythraea are therefore expected.
According to our data, the differential expression be-
tween overproducer E3 and wild-type NRRL23338 signifi-
cantly involved transport of phosphate and nitrogen, and
phosphate starvation response and repressive nitrogen-
metabolism was observed in E3 through entire time-
course compared with NRRL2338 strain. This suggests
that the high-level expression of erythromycin biosyn-
thesis pathway probably result from the dysfunction of
global regulators sensing stress or nutritional starvation
signal, as is known in the signaling system of PhoP-AfsR-
AfsS in S. coelicolor A3(2), controlling expression of genes
involved in P-N nutrition stress response and secondary
metabolism [47]. AfsS, a 63-amino-acid sigma-like regu-
latory protein, was found in streptomycetes including
S. coelicolor, S. dividans, S. griseus, and S. noursei. In
S. coelicolor, the activation of AfsS by AfsR can further
activate the transcription of genes coding for pathway-
specific transcription factors, e.g. actII-ORF4 and More-
over, AfsS, as a crucial master regulator of both antibiotic
synthesis and nutritional stress response, also regulates
the expression of genes involved in phosphate transport
and nitrogen metabolism. The global network of signal
transduction cascades and cross-talk of PhoP and AfsR-
AfsS was modeled recently, which controls gene expres-
sion involved in P-N balance and secondary metabolism
in S. coelicolor [48-50]. PhoP repressed the transcription
of nitrogen genes by binding to the promoter of glnR, the
major nitrogen regulator, to the promoters of glnA and
glnII, two glutamine synthetases, and to the promoter of
the amtB-glnK-glnD operon, encoding an ammonium
transporter [51]. It is interesting that the S. erythraea
orthologs of these genes and other GlnR-regulon genes
were significantly down-regulated in strain E3, such as
glnR (SACE_7101), glnB (SACE_6061) encoding the nitro-
gen regulatory protein PII, amt (SACE_6062), glnA-1
(SACE 1623) coding for the glutamine synthetase, ure op-
erons (SACE_0634-0636, SACE_2526-2527) coding for
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the assimilatory nitrite reductase and nitrite extrusion pro-
tein. The previous works also demonstrated that many
genes related to nitrogen metabolism showed lower expres-
sion in S. erythraea overproducing strain rif1 with S444F
mutation in rpoB than in impaired strain rif6 with Q426R
mutation [6]. In order to investigate if these nitrogen
metabolism genes are under the control of PhoP in
S. erythraea, we searched these genes for PHO boxes using
the model based on the alignment of 25 PHO DRu com-
piled by Blanco et al. [52], and detected one candidate
PHO box (two DRus: GTTCGCCTTCTGTTCACAATTG)
in the glnR promoter region, and one (two DRus:
CTTCCCGTGCCGTTCAGCAACG) in the afsR pro-
moter. However, we failed to find sequences coding AfsS-
like protein in S. erythraea genome. So far the signaling
system of PhoP-AfsR-AfsS, controlling expression of genes
involved in P-N nutrition stress response and secondary
metabolism in S. erythraea has not been built. Our findings
suggest the existence of a similar regulation mechanism
underlying the erythromycin biosynthesis in S. erythraea
(Figure 4).
Taken together, it seems that the regulatory mechan-
ism of erythromycin biosynthesis is much more compli-
cated than expected, probably involving more than one
global regulator. Further function experiments, such as
the identification of the regulators and their target genes,
the identification of PhoP-AfsR-AfsS signaling system,
will help to elucidate the precise mechanisms. Further-
more, the accumulation of genomic and transcriptomic
data for more over-producing strains will also help to
find out the causal variations which directly contribute
to antibiotic production. Actually, a comparative genom-
ics and transciptomic profiles of another erythromycin
over-producing strain Px and NRRL2338 was released
very recently [53]. It was found that the genomic varia-
tions affect a total of 227 proteins of Px strain and a
quite number of mutations alter key enzymes in the
central carbon and nitrogen metabolism and in theFigure 4 Putative regulatory roles of PhoP, GlnR, and AfsR in phosph
S. erythraea.biosynthesis of secondary metabolites, which probably
results in the redirection of common precursors for
erythromycin biosynthesis [53]. Similar to the current
report, it is difficult to sort out the mutations which are
directly related to the high production of erythromycin.
Besides experimental verification, next efforts on the
comparison of different overproducers by using ad-
vanced data integration techniques will help to generate
more insights on the regulation mechanism of erythro-
mycin biosynthesis, and eventually provide valuable in-
formation on new strategies for strain improvement.Conclusions
In this work, we sequenced the whole genome of a high-
producing S. erythraea strain E3 obtained by random
mutagenesis and screening from the wild-type strain
NRRL23338, and examined time-series expression pro-
files of both E3 and NRRL23338. Based on the genomic
data and transcriptpmic data of these two strains, we
carried out comparative analysis of high-producing
strain and wild-type strain at both the genomic level and
the transcriptomic level. A large number of genomic var-
iations, including 60 insertions, 46 deletions and 584 sin-
gle nucleotide variations (SNV) were identified in E3 in
comparison with NRRL23338, and the analysis of time
series transcriptomic data indicated that the genes in-
volved in erythromycin biosynthesis and feeder pathways
were significantly up-regulated during the 60 hours
time-course. According to our data, BldD, a previously
identified ery cluster regulator, did not show any positive
correlations with the expression of ery cluster, suggesting
the existence of alternative regulation mechanisms of
erythromycin synthesis in S. erythraea. Several potential
regulators were then proposed by integration analysis of
genomic and transcriptomic data. This functional com-
parative genomics work represents an important step to-
wards understanding the over-producing mechanism of
S. erythraea strain E3 on a genomic scale, and providedate, nitrogen metabolism and erythromycin biosynthesis in
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tion of erythromycin.
Methods
Bacterial strains and culture conditions
Two S. erythraea strains, the wild-type NRRL23338 and
a high-producing strain E3, were used in this study.
S. erythraea strains were grown on agar plates of the
medium [10 g cornstarch, 10 g corn steep liquor, 3 g
NaCl, 3 g (NH4)2SO4, 2 g CaCO3, and 2 g agar per liter
of distilled H2O, pH 7.2] at 34°C for sporulation. An
agar piece about 1 cm2 was inoculated into a 500 ml
flask containing 50 ml of the seed medium [50 g/L corn-
starch, 18 g/L soybean flour, 13 g/L corn steep liquor,
3 g/L NaCl, 1 g/L (NH4)2SO4, 1 g/L NH4NO3, 5 g/L
soybean oil, and 6 g/L CaCO3, pH 6.8 to 7.0] and grown
for 48 h at 34°C and 200 rpm, then added 5 ml of the
seed culture to a 500 ml flask containing 60 ml of the
fresh industrail fermentation medium, incubation was
continued at 34°C and 200 rpm for 4 days. The
industrail medium consists of 40 g/L cornstarch, 30 g/L
soybean flour, 30 g/L dextrin, 2 g/L (NH4)2SO4, 10 g/L
soybean oil, and 6 g/L CaCO3 (pH 7.0 to 7.2). All media
types were sterilized by autoclaving at 121°C for 30 min.
Both supernatant and cell pellet samples (1 ml) were
harvested at six different time points (10 h, 16 h, 24 h,
36 h, 48 h, and 60 h) during 4 days culture period, and
erythromycin titers and biomass were determined. My-
celium for RNA isolation were immediately quenched in
liquid nitrogen, and stored at −80°C until further use.
Two independently cultured replicates were performed
for the two strains fermentation experiment.
Erythromycin titer measurements
The amount of the erythromycin produced in the fer-
mentation broth was determined by means of biological
method. Bioassays for erythromycin were performed
using a large plate double-agar layer system. The bottom
agar layer consisted of the test medium (5 g peptone, 3 g
beef extract, 3 g K2HPO4, and 15 g agar per liter of dis-
tilled H2O) without Bacillus pumilus culture. Once the
bottom layer was solidified, a top agar layer (contains
B. pumilus culture) was poured. After the upper layer
was solidified at room temperature, fermentation super-
natant (260 μl) was added to stainless steel cylinders on
agar plates. The bioassay plates were incubated over-
night at 37°C. After incubation, the erythromycin pro-
duction was estimated by measuring the diameters of
the inhibition zones and calculated according to the cali-
bration curve made by using the commercially available
erythromycin as a control. Whereas two strains grew at
similar rates, the E3 strain produced about 30-fold more
erythromycin (600 mg/L) than the NRRL23338 strain
(20 mg/L) (Additional file 5: Figure S1).Genome sequencing and assembly
The nucleotide sequence of the S. erytheraea strain E3
genome was determined by using a massively parallel
pyrosequencing technology (Roche 454 GS FLX). A total
of 273 contigs (>500 bp) with a total size of 8.2 Mb were
assembled from 876,307 reads (average length of 238 bp)
using Newbler software of the 454 suite package, provid-
ing a 25-fold coverage. Relationship among contigs was
determined using the genome of S. erytheraea NRRL
23338 as reference, and validated by PCR. Gaps between
contigs were filled by sequencing PCR products. The
final sequence assembly was carried out using phred/phrap/
consed package (http://www.phrap.org/phredphrapconsed.
html), and all the low sequence quality regions, including ho-
mopolymeric sites, were resequenced using PCR Sanger se-
quencing. The final sequencing accuracy of genome was
99.9965%.
Genome annotation and analysis
CDSs were predicted by using Genemark (http://exon.
biology.gatech.edu/) [54] and Glimmer (http://ccb.jhu.
edu/software/glimmer/index.shtml) [55], and manually cu-
rated. Functional annotation of CDSs was performed
through comparisons to NCBI nr database using BLASTP
(2.2.14) [56] and classified according to COGs (http://
www.ncbi.nlm.nih.gov/COG/) [31] and Gene Ontology
(http://www.geneontology.org/) [57]. Transfer RNA genes
were predicted with tRNAscan-SE [58]. Whole genome
alignment between strain E3 and NRRL23338 were
performed by using BLASTN (2.2.14) [56].
Microarray construction and transcript profiling
The S. erythraea DNA microarrays (SER v1.0) were cus-
tomized using Agilent eArray 6.0 according to the manu-
facturer’s recommendations (https://earray.chem.agilent.
com/earray/).
Each customized microarray (8x15K) contained spots
in duplicate with 7,198 gene-specific 60-mer oligonucleo-
tide probes interrogating the 7,198 predicted ORFs in
S. erythraea (as reported for the S. erythraea genome
at http://131.111.43.95/gnmweb/index.html). RNA was ex-
tracted from mycelium pellets deriving from two independ-
ent culture samples using the Column Plant RNAout
(TIANDZ) according to the standard protocols. The RNAs
were subsequently purified by QIAGEN RNeasy Mini Kit.
The quality and quantity were determined by nanodrop
UV spectroscopy (Ocean Optics) and analysis on a RNA
6000 Nano LabChip (Agilent Technologies) using a 2100
bioanalyzer (Agilent Technologies). RNA samples were
processed and hybridized to the customized chips SER v1.0.
Data processing and analysis
Data quality assessment and normalization were per-
formed by using limma package in Bioconductor [59]. The
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course package [60] in terms of between- time series by
comparing time-course mean profiles with multivariate
empirical Bayes model [61].
A recently published differential coexpression analysis
method (‘DCp’) was applied to explore differentially
coexpressed genes (DCGs) [35]. When constructing the
coexpression networks for two contrastive strains, the
correlation cutoff was set as 0.8 to filter coexpression
links. The differentially coexpressed genes (DCGs) were
ranked according to their p values.
Protein structure modeling
Homology modeling was applied to predict three-
dimensional structures of the interested proteins. We
first searched PDB (http://www.rcsb.org) for putative
structural templates using NCBI BLAST [62] with se-
quence identity greater than 30%. After that, only the
best template was kept according to the alignment
coverage, sequence identity and structural resolution in
combination. MODELLER was then adopted to con-
cisely align the interested protein to its template, and
build the three-dimensional homology model automatic-
ally [63]. DOPE score, as suggested by the manual of
MODELLER, was used to sort out the best structure
model from all those generated. The selected models
were analyzed in PyMOL (http://www.pymol.org/).
Motif search method
The positional weight matrix (PWM) was generated
according to the literature [64]. Upstream 300 bp and
downstream 50 bp from the gene start positions were
scanned by Patser to find potential target regulated
genes and TFBSs [65].
Additional files
Additional file 1: Table S1. All nucleotide variations detected in E3
compared with NRRL23338.
Additional file 2: Table S2. Single amino acid substitution detected in
E3 compared with NRL23338.
Additional file 3: Table S3. Amino acid deletion detected in E3
compared with NRRL23338.
Additional file 4: Table S4. Amino acid insertion detected in E3
compared with NRRL23338.
Additional file 5: Figure S1. Erythromycin production curve during the
time-course for the industrial S. erythraea strain and the wild-type
NRRL23338 strain. E1 and E2 are two replicates for the industrial strain;
M1 and M2 are two replicates for the wild-type strain.
Additional file 6: Table S5. Genome annotation of S. erythraea
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Additional file 7: Table S6. COG classification of differentially
expressed genes.
Additional file 8: Table S7. Gene expression data.
Additional file 9: Table S8. Regulators involving amino acid variation.Additional file 10: Dataset S1. Sequence alignment results of
18 regulators.
Additional file 11: Figure S2. Structural Models of MtrA (V197 H198
deletion): SACE_6447 and ETHR_6255. His197 and Val198 of SACE_6447
(A), deleted in ETHR_6255 (B), are located in the center of an α-helix. The
deletions are supposed to break the helix and to perturb the DNA-
binding function of Val196 in the active state. In addition, His197
contributes to the inter-domain interactions in the inactive state, and its
deletion would thus affect the stability of ETHR_6255.
Additional file 12: Figure S3. Structural Models of MoxR (N133D):
SACE_3795 and ETHR_3703. The Asn133 in SACE_3795 (A), substituted by
Asp133 in ETHR_6255 (B), is located in the vicinity of Asp130 and Asn172,
both of which were annotated as ATP-binding sites according to NCBI
CDD. The Asn133 may thereby be implicated in the ATP-binding through
the proxy of Asp130 and Asn172, or even through direct interaction with
ATP. In addition, the nearby residues 128–131 are also putative ‘Walker B
motif’, which is important for interacting with Mg2+ cation. So the
substitution of Asn133 to Asp133, resulting in negative charge on the
side chain, may affect the ATP-binding or Mg2+ cation-binding of the
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